Trials / Active Not Recruiting
Active Not RecruitingNCT06920212
Clinical Safety and Efficacy of Fecal Microbiota Transplantation (FMT) in the Treatment of Alzheimer's Disease
Clinical Safety and Efficacy of FMT in the Treatment of Alzheimer's Disease
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Shanghai 10th People's Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the clinical safety and efficacy of FMT in AD patients, as well as the changes in the gut microbiota of AD patients before and after FMT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | FMT capsule | Fecal microbiota transplantation (FMT) is a method for treating imbalances in the intestinal microbiota. Its basic principle involves extracting a portion of feces from a healthy individual that contains a diverse population of beneficial bacteria, processing it, and transplanting it into the digestive system of the recipient to restore a balanced intestinal microbiota. |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-10-31
- Completion
- 2025-12-31
- First posted
- 2025-04-09
- Last updated
- 2025-04-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06920212. Inclusion in this directory is not an endorsement.